Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Abstract #975885: Euglycemic Diabetic Ketoacidosis Secondary to SGLT2-inhibitor Use in Combination with a Ketogenic Diet: A Case Report

Joi C. Hester,Stacy Zimmerman, Teresa Nimmo, Wesley Cunningham, Joshua Liu,Suporn Sukpraprut-Braaten,Francisco Pasquel

Endocrine Practice（2021）

Cited 0|Views0
No score
Abstract
Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are cardiorenal protective agents increasingly used in patients with diabetes. Cases of euglycemic diabetic ketoacidosis (euDKA) have been reported particularly among patients with type 1 diabetes. Our case is an example that highlights the role SGLT-2 inhibitors play in the development of euDKA in a patient with type 2 diabetes with confounding factors of strict adherence to a ketogenic diet and ankle fracture.
More
Translated text
Key words
Type 2 Diabetes,Glucose Transporter Deficiency,SGLT2 Inhibitors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined